Drug General Information
Drug ID	D02ZBW
Former ID	DIB005411
Drug Name	LC-150444
Synonyms	LCD15-0444; Dipeptidyl peptidase IV inhibitors (oral, type 2 diabetes), LG Life Sciences
Indication	Type 2 diabetes [ICD9: 250; ICD10:E11]		Phase 3	[524679]
Company	LG Life Sciences Ltd
Structure		Download 2D MOL 3D MOL
Canonical SMILES	N1(CCCC1C(=O)c1oc(nn1)c1ccccc1)C(=O)CNC(COC)(C)C
Target and Pathway
Target(s)	Dipeptidyl peptidase IV	Target Info	Inhibitor	[550262]
KEGG Pathway	Protein digestion and absorption
NetPath Pathway	IL2 Signaling Pathway
	TGF_beta_Receptor Signaling Pathway
References
Ref 524679	ClinicalTrials.gov (NCT02089126) Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes. U.S.National Institutes of Health.
Ref 550262	Clinical pipeline report, company report or official report of ShangHai APIs Chemical.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.